Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Downgrades Saia to Peer Perform

Wolfe Research Downgrades Saia to Peer Perform

Wolfe Research analyst Scott Group downgrades Saia (NASDAQ:SAIA) from Outperform to Peer Perform.

byBenzinga Newsdesk

November 17, 2022

1 minute read

Wolfe Research analyst Scott Group downgrades Saia (NASDAQ:SAIA) from Outperform to Peer Perform.

Why CrowdStrike, Zscaler And Okta Shares Are Rising After Hours

By Adam Eckert

February 21, 5:52 PM

Several cybersecurity stocks including CrowdStrike Holdings Inc (NASDAQ: CRWD), Zscaler Inc (NASDAQ: ZS) and Okta Inc (N

CRWD

MicroStrategy’s Winning Streak: How Bitcoin Holdings Sparked a $1.92B Blow to Short Sellers

By Anusuya Lahiri

April 11, 2:19 PM

MicroStrategy Inc (NASDAQ: MSTR) has faced $1.92B losses due to short sellers' bets. Its stock outperformed bitcoin, aided by SEC-approved ETFs.

CLSK

Mizuho Reiterates Buy on Oracle, Maintains $116 Price Target

By Benzinga Newsdesk

March 6, 8:48 AM

Mizuho analyst Siti Panigrahi reiterates Oracle (NYSE:ORCL) with a Buy and maintains $116 price target.

ORCL

Ocuphire Pharma Announces Presentation On APX3330 At The Annual Angiogenesis, Exudation, And Degeneration 2024 Conference

By Benzinga Newsdesk

February 5, 9:05 AM

Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders,

OCUP

Wolfe Research Downgrades Saia to Peer Perform

Related Posts

Why CrowdStrike, Zscaler And Okta Shares Are Rising After Hours

MicroStrategy’s Winning Streak: How Bitcoin Holdings Sparked a $1.92B Blow to Short Sellers

Mizuho Reiterates Buy on Oracle, Maintains $116 Price Target

Ocuphire Pharma Announces Presentation On APX3330 At The Annual Angiogenesis, Exudation, And Degeneration 2024 Conference